Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
The total investment incurred for setting up the new R&D is Rs 250 crore
Cabinet approves ‘Bio-RIDE’ scheme to support R&D in Biotechnology
The scheme is part of the Government of India’s mission to harness the potential of bio-innovation to tackle national and global…
Eppendorf India and Rajalakshmi Engineering College sign MoU for training students
A team of Eppendorf experts would conduct the training on various modules such as liquid handling, centrifugation, extraction and…
Piramal Pharma’s GHG commitment validated and approved by SBTi
Piramal has committed to reducing absolute scope 1 and 2 GHG emissions by 42 per cent by FY2030 from an FY2022 base year. It has…
Industry hails Bio E3 policy as transformative for India’s biotech sector
Aim to spur India's bio economy to an aspirational $300 billion by 2030
Pfizer sets up Analytics Gateway capability centre in India
The capability centre aims to accelerate Pfizer’s growth across the 140 countries (ex-US) where it is present, powered by data,…
Lupin gets US FDA nod for Bumetanide Injection, USP
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of $ 20 million in the US (IQVIA MAT July 2024)
DBT-BIRAC partners with Blockchain For Impact to accelerate bio-medical innovation in India
Aligned to the recently approved BioE3 policy, the partnership will fast-track innovation and tech-driven support in the…
Lupin partners with Takeda to commercialise Vonoprazan
The drug will be marketed under the brand name Lupin’s Lupivon and will be available in two strengths - 10 mg and 20 mg
Eugia Steriles receives EIR from US FDA
The inspection was conducted between March 28, 2024 to April 05, 2024